Blood derivatives maker Imuna has begun production again following its purchase last year in a bankruptcy tender by investor Pharm Holding.
Compiled by Tom Nicholson from press reports.
The Slovak Spectator cannot vouch for the accuracy of the information presented in its Flash News postings.
22. Jan 2003 at 12:50
